|Podcasts|December 1, 2011

Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them

Sam Whitaker, CEO of Greenphire, discusses the company’s success to date with its financial payments technology, global capabilities for next year, and how financial pressures are changing trials for the better.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Trending on Applied Clinical Trials Online

Greenphire CEO Sam Whitaker Discusses the Financial Pain Points for the Investigative Site, and How to Solve Them

Related Content

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast

Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit

Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development

The Evolving Relationship Between Sponsors and the Contract Research Organizations

The MDR: Navigating Europe’s New Standard for Medical Device Safety

Trending on Applied Clinical Trials Online

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

ACT Brief: Payment Infrastructure and Site Cash, Inspection Readiness Throughout Execution, and First Hemolytic Anemia Therapy

Connected Trial Execution: Why Integrating IRT, eCOA and Clinical Supply Matters More Than Ever